![Douglas P. Malinowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas P. Malinowski
Chief Tech/Sci/R&D Officer at TriPath Oncology, Inc.
Profile
Douglas P.
Malinowski has been Vice President of Research and Chief Scientific Officer of TriPath Oncology Inc. since November, 2001.
Prior to joining TriPath Oncology, he worked at Becton Dickinson & Co. which he joined in 1983.
He worked at the Becton Dickinson Corporate Research Center (BDRC).
Dr. Malinowski received a BS degree in Chemistry from the University of Notre Dame and a PhD degree in Biochemistry from the Duke University Medical Center.
Douglas P. Malinowski active positions
Companies | Position | Start |
---|---|---|
TriPath Oncology, Inc.
![]() TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Douglas P. Malinowski
Companies | Position | End |
---|---|---|
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Training of Douglas P. Malinowski
University of Notre Dame | Undergraduate Degree |
Duke University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BECTON, DICKINSON AND COMPANY | Health Technology |
Private companies | 1 |
---|---|
TriPath Oncology, Inc.
![]() TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Commercial Services |
- Stock Market
- Insiders
- Douglas P. Malinowski